• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病患者血糖风险指数与颈动脉内膜中层厚度的关联

Association between glycemia risk index and carotid intima-media thickness in type 2 diabetes.

作者信息

Zhao Lingyun, Heng Hongyan, Xie Qinyuan, Liang Chenghong, Guo Sijia, Zhang Ziyi, Yuan Huijuan

机构信息

Department of Endocrinology, Zhengzhou University People's Hospital, Zhengzhou, China.

Department of Endocrinology, Henan Provincial Key Medicine Laboratory of Intestinal Microecology and Diabetes, Diabetes Microecology Diagnosis and Treatment and Transformation Engineering Research Center of Henan Province, Henan Provincial People's Hospital, Zhengzhou, China.

出版信息

Front Endocrinol (Lausanne). 2025 Jun 19;16:1563734. doi: 10.3389/fendo.2025.1563734. eCollection 2025.

DOI:10.3389/fendo.2025.1563734
PMID:40612434
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12224650/
Abstract

OBJECTIVE

To investigate the association between the Glycemic Risk Index (GRI) and carotid intima-media thickness (CIMT) in type 2 diabetes mellitus (T2DM) patients and evaluate the clinical utility of GRI for early vascular risk assessment.

METHODS

This retrospective study included 450 previously untreated patients with T2DM prior to hospitalization. We calculated GRI using CGM data and assessed CIMT with high-resolution ultrasound. Multiple linear and logistic regression analyses assessed the association between GRI and CIMT. Receiver operating characteristic (ROC) curve analyses evaluated GRI's predictive performance.

RESULTS

There was a significant positive correlation between GRI and CIMT (r = 0.42, P < 0.001). After adjusting for confounders, GRI remained an independent predictor of CIMT thickening (OR = 7.226, 95% CI: 5.597-8.856, P < 0.001). ROC analysis revealed that GRI alone predicted abnormal CIMT with an AUC of 0.869.

CONCLUSION

GRI is a robust marker for predicting CIMT thickening in T2DM patients, providing a novel approach for cardiovascular risk stratification. This study underscores the potential of integrating GRI into routine diabetes management to improve vascular outcomes.

摘要

目的

探讨2型糖尿病(T2DM)患者的血糖风险指数(GRI)与颈动脉内膜中层厚度(CIMT)之间的关联,并评估GRI在早期血管风险评估中的临床应用价值。

方法

这项回顾性研究纳入了450例住院前未经治疗的T2DM患者。我们使用连续血糖监测(CGM)数据计算GRI,并采用高分辨率超声评估CIMT。多元线性和逻辑回归分析评估GRI与CIMT之间的关联。受试者工作特征(ROC)曲线分析评估GRI的预测性能。

结果

GRI与CIMT之间存在显著正相关(r = 0.42,P < 0.001)。在调整混杂因素后,GRI仍然是CIMT增厚的独立预测因素(OR = 7.226,95%CI:5.597 - 8.856,P < 0.001)。ROC分析显示,单独使用GRI预测CIMT异常的曲线下面积(AUC)为0.869。

结论

GRI是预测T2DM患者CIMT增厚的可靠标志物,为心血管风险分层提供了一种新方法。本研究强调了将GRI纳入常规糖尿病管理以改善血管结局的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56c2/12224650/644115393f8f/fendo-16-1563734-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56c2/12224650/b7ef97504de7/fendo-16-1563734-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56c2/12224650/644115393f8f/fendo-16-1563734-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56c2/12224650/b7ef97504de7/fendo-16-1563734-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/56c2/12224650/644115393f8f/fendo-16-1563734-g002.jpg

相似文献

1
Association between glycemia risk index and carotid intima-media thickness in type 2 diabetes.2型糖尿病患者血糖风险指数与颈动脉内膜中层厚度的关联
Front Endocrinol (Lausanne). 2025 Jun 19;16:1563734. doi: 10.3389/fendo.2025.1563734. eCollection 2025.
2
Evaluation of the ultrasonic arterial measurement and analysis system for predicting 10-year atherosclerotic cardiovascular disease risk in patients with type 2 diabetes.评估用于预测2型糖尿病患者10年动脉粥样硬化性心血管疾病风险的超声动脉测量与分析系统。
Quant Imaging Med Surg. 2025 Jun 6;15(6):4921-4934. doi: 10.21037/qims-24-1620. Epub 2025 Jun 3.
3
Glycated hemoglobin is not enough: The role of glycemia risk index for glycemic control assessment in type 1 diabetes.糖化血红蛋白并不够:血糖风险指数在1型糖尿病血糖控制评估中的作用
World J Diabetes. 2025 Jun 15;16(6):104024. doi: 10.4239/wjd.v16.i6.104024.
4
Glycemic control and asymptomatic carotid plaque and carotid intima-media thickness.血糖控制与无症状性颈动脉斑块及颈动脉内膜中层厚度
BMJ Open Diabetes Res Care. 2025 Jun 18;13(3):e004786. doi: 10.1136/bmjdrc-2024-004786.
5
Carotid Intima-Media Thickness, Carotid Distensibility, and Incident Heart Failure in Older Men: The British Regional Heart Study.老年男性的颈动脉内膜中层厚度、颈动脉扩张性与心力衰竭发病:英国地区心脏研究
J Am Heart Assoc. 2025 Apr;14(7):e037167. doi: 10.1161/JAHA.124.037167. Epub 2025 Mar 21.
6
Glycemia Risk Index (GRI) and international glucose targets before and 6 months after initiation of hybrid closed loop system in the CIRDIA, a French multisite out-of-hospital center.在法国多中心院外中心CIRDIA启动混合闭环系统之前及之后6个月的血糖风险指数(GRI)和国际血糖目标
Diabetes Metab. 2025 Mar;51(2):101617. doi: 10.1016/j.diabet.2025.101617. Epub 2025 Feb 6.
7
Machine learning-based prediction of carotid intima-media thickness progression: a three-year prospective cohort study.基于机器学习的颈动脉内膜中层厚度进展预测:一项为期三年的前瞻性队列研究。
Front Med (Lausanne). 2025 Jun 12;12:1593662. doi: 10.3389/fmed.2025.1593662. eCollection 2025.
8
Health Literacy in Patients With Acute Stroke Is Associated With Carotid Intima-Media Wall Thickness: A Cross-Sectional Study.急性卒中患者的健康素养与颈动脉内膜中层厚度相关:一项横断面研究。
Physiother Res Int. 2025 Jul;30(3):e70087. doi: 10.1002/pri.70087.
9
Association between multiple sleep dimensions in obstructive sleep apnea and an early sign of atherosclerosis.阻塞性睡眠呼吸暂停中多个睡眠维度与动脉粥样硬化早期迹象之间的关联。
J Clin Sleep Med. 2024 Jul 1;20(7):1093-1104. doi: 10.5664/jcsm.11090.
10
Relation between age and carotid artery intima-medial thickness: a systematic review.年龄与颈动脉内膜中层厚度之间的关系:一项系统评价
Clin Cardiol. 2018 May;41(5):698-704. doi: 10.1002/clc.22934. Epub 2018 May 12.

本文引用的文献

1
Association of Glycaemia Risk Index With Indices of Atherosclerosis: A Cross-Sectional Study.血糖风险指数与动脉粥样硬化指标的关联:一项横断面研究。
J Diabetes. 2025 Mar;17(3):e70065. doi: 10.1111/1753-0407.70065.
2
The Interplay Between Immunity, Inflammation and Endothelial Dysfunction.免疫、炎症与内皮功能障碍之间的相互作用
Int J Mol Sci. 2025 Feb 17;26(4):1708. doi: 10.3390/ijms26041708.
3
Quantitative prediction of toxicological points of departure using two-stage machine learning models: A new approach methodology (NAM) for chemical risk assessment.
使用两阶段机器学习模型进行毒理学出发点的定量预测:一种用于化学风险评估的新方法学(NAM)
J Hazard Mater. 2025 Apr 5;487:137071. doi: 10.1016/j.jhazmat.2024.137071. Epub 2025 Jan 10.
4
Glycemic profile variability as an independent predictor of diabetic retinopathy in patients with type 2 diabetes: a prospective cohort study.血糖谱变异性作为 2 型糖尿病患者糖尿病视网膜病变的独立预测因子:一项前瞻性队列研究。
Front Endocrinol (Lausanne). 2024 Nov 7;15:1383345. doi: 10.3389/fendo.2024.1383345. eCollection 2024.
5
Glycemic variability assessed using continuous glucose monitoring in individuals without diabetes and associations with cardiometabolic risk markers: A systematic review and meta-analysis.使用连续血糖监测评估无糖尿病个体的血糖变异性及其与心血管代谢风险标志物的相关性:系统评价和荟萃分析。
Clin Nutr. 2024 Apr;43(4):915-925. doi: 10.1016/j.clnu.2024.02.014. Epub 2024 Feb 22.
6
Association between glycemia risk index and arterial stiffness in type 2 diabetes.血糖风险指数与 2 型糖尿病患者动脉僵硬的关系。
J Diabetes Investig. 2024 May;15(5):614-622. doi: 10.1111/jdi.14153. Epub 2024 Jan 22.
7
Common mechanisms underlying diabetic vascular complications: focus on the interaction of metabolic disorders, immuno-inflammation, and endothelial dysfunction.糖尿病血管并发症的共同发病机制:聚焦于代谢紊乱、免疫炎症和内皮功能障碍的相互作用。
Cell Commun Signal. 2023 Oct 30;21(1):298. doi: 10.1186/s12964-022-01016-w.
8
Impact of glucose variability on the assessment of the glycemia risk index (GRI) and classic glycemic metrics.血糖变异性对血糖风险指数(GRI)和经典血糖指标评估的影响。
Endocrine. 2023 Dec;82(3):560-568. doi: 10.1007/s12020-023-03511-7. Epub 2023 Sep 11.
9
Comparison of Glycemia Risk Index with Time in Range for Assessing Glycemic Quality.血糖风险指数与血糖达标时间比较评估血糖质量。
Diabetes Technol Ther. 2023 Dec;25(12):883-892. doi: 10.1089/dia.2023.0264. Epub 2023 Oct 25.
10
The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction.氧化应激在糖尿病性血管内皮功能障碍中的作用。
Cardiovasc Diabetol. 2023 Sep 2;22(1):237. doi: 10.1186/s12933-023-01965-7.